Obtaining Valid Laboratory Data in Clinical Trials Conducted in Resource Diverse Settings: Lessons Learned from a Microbicide Phase III Clinical Trial

• Tania Crucitti ,

  * E-mail: tcrucitti@itg.be

  Affiliation HIV/STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Katrien Fransen,

  Affiliation HIV/STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Rashika Maharaj,

  Affiliation HIV Prevention Research Unit, Medical Research Council, Durban, South Africa

  ⨯
• Tom Tenywa,

  Affiliation STI Reference Laboratory, Makarere University, Kampala, Uganda

  ⨯
• Marguerite Massinga Loembé,

  Affiliations Département de Médecine Sociale et Préventive, Université Laval, Quebec, Canada, Unité de Recherche en Santé des Populations, Centre Hospitalier Affilié Universitaire de Québec, Quebec, Canada, Centre Hospitalier Affilié Universitaire de Québec, Quebec, Canada

  ⨯
• Kailapuri Gangatharan Murugavel,

  Affiliation Y. R. Gaitonde Center for AIDS Research and Education (Y. R. G. CARE), Voluntary Health Services Campus, Chennai, India

  ⨯
• Kevin Mendonca,

  Affiliation Population Health and Clinical Research, St. John's Medical College, Bangalore, India

  ⨯
• Said Abdellati,

  Affiliation HIV/STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Greet Beelaert,

  Affiliation HIV/STI Reference Laboratory, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Lut Van Damme

  Affiliations CONRAD, Arlington, Virginia, United States of America, Family Health International, Research Triangle Park, North Carolina, United States of America

  ⨯